Efficacy and Safety of Using Autologous Dendritic Cells Combined with Cytokine-Induced Killer Cells as an Adjuvant Therapy on Advanced Malignant Melanoma

Keqian Zhang^1#, Ran Sun^2#, Zhi Yang², Yu Peng¹, Jie Zhou¹ and Zhihua Ruan^1*

¹Department of Oncology, Southwest Cancer Center, The First Affiliated Hospital of Third Military Medical University (Army Medical University), PR China

²Biological Treatment Center, The First Affiliated Hospital of Third Military Medical University (Army Medical University), PR China

^#Contributed equally to this work

^*Corresponding Author: Zhihua Ruan, Department of Oncology, Southwest Cancer Center, the First Affiliated Hospital of Third Military Medical University (Army Medical University), 29 Gaotanyan Main Street; Shapingba District; Chongqing 400038, PR China, Tel: +(86)23 68765192 Email:

Keywords: Malignant melanoma; Immunotherapy; Dendritic cells; Cytokine induced killer cells; Progression-free survival; Overall survival.

Abbreviations